Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Atropine[1] Atropine[5] D00113 (Name: Atropine),
D01077 (Name: Atropine methonitrate (JAN/INN)),
D02069 (Name: Atropine sulfate),
D03011 (Name: Atropine oxide hydrochloride),
D03814 (Name: Atropine methylbromide)		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 2
2Scopolamine, atropine, edaravone and dexmedetomidine[4] Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine		[9] D00113 (Name: Atropine),
D00138 ,
D00514 ,
D01077 (Name: Atropine methonitrate (JAN/INN)),
D01205 ,
D01552 ,
D02069 (Name: Atropine sulfate),
D03011 (Name: Atropine oxide hydrochloride),
D03814 (Name: Atropine methylbromide)		[8] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2